logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
15/05/2025
In March, the number of building permits in Canada decreased by 4.1% compared to the previous month; it is expected to decrease by 1.2%.
Latest
5 m ago
Craig-Hallum: Maintaining Fennec Pharmaceuticals (FENC.US) rating, adjusting from Buy to Buy rating, target price adjusted from $12.00 to $13.00.
8 m ago
Craig-Hallum: Maintain rating for Biodesix (BDSX.US), adjusting from buy to hold rating, target price adjusted from $3.00 to $1.50.
10 m ago
Craig-Hallum: Maintains a buy rating for Eton Pharmaceuticals (ETON.US), adjusted from a buy rating to a buy rating, with a target price adjusted from $26.00 to $28.00.
12 m ago
HC Wainwright & Co. maintains its rating on Revolution Medicines (RVMD.US) and adjusts its recommendation from buy to buy, with a target price adjustment from $73.00 to $72.00.
12 m ago
Citigroup: Maintains a neutral rating on Lowe's Companies (LOW.US), adjusting the target price from $269.00 to $253.00.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.